Literature DB >> 3887159

Therapeutic effect of propranolol on paradoxical hypertension after repair of coarctation of the aorta.

S S Gidding, A P Rocchini, R Beekman, C A Szpunar, C Moorehead, D Behrendt, A Rosenthal.   

Abstract

Patients undergoing repair of coarctation of the aorta often have self-limited but severe hypertension in the first week after surgery (paradoxical hypertension). We conducted a controlled trial of treatment with propranolol before repair of coarctation of the aorta in 14 children to determine whether the drug would prevent paradoxical hypertension. Seven patients were randomly assigned to receive propranolol for two weeks before surgery and throughout the first postoperative week, and seven patients were assigned to receive standard postoperative care. Both groups had a similar significant (P less than 0.05) increase in the plasma norepinephrine level in response to surgery; however, when compared with no treatment, treatment with propranolol reduced not only the rise in systolic (P = 0.004) and diastolic (P = 0.003) blood pressure but also the postoperative increase in plasma renin activity (P less than 0.01). We conclude that prophylactic propranolol can prevent paradoxical hypertension and should therefore become a routine part of the operative care of patients with coarctation of the aorta.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3887159     DOI: 10.1056/NEJM198505093121904

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  9 in total

1.  Reversal of left ventricular hypertrophy by propranolol in hypertensive rats.

Authors:  Charles I Maina; Maurice Ogunde
Journal:  Afr Health Sci       Date:  2005-03       Impact factor: 0.927

2.  Incidence of adverse events requiring intervention after initiation of oral beta-blocker in pediatric cardiac intensive care patients.

Authors:  Jolie Britt; Brady S Moffett; Ronald A Bronicki; Paul A Checchia
Journal:  Pediatr Cardiol       Date:  2014-04-10       Impact factor: 1.655

3.  Variability in Treatment of Post-coarctectomy Hypertension: A Multicenter Study.

Authors:  Brady S Moffett; Daniel J Penny
Journal:  Pediatr Cardiol       Date:  2016-02-20       Impact factor: 1.655

Review 4.  Rational use of antihypertensive medications in children.

Authors:  Michael A Ferguson; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2013-05-29       Impact factor: 3.714

5.  Post-op systemic hypertensive crises in an infant with total anomalous pulmonary venous connection.

Authors:  Vikas Kohli; Manvinder S Sachdev; Reena K Joshi; Raja Joshi
Journal:  Indian J Pediatr       Date:  2009-05-27       Impact factor: 1.967

6.  Pharmacodynamics and pharmacokinetics of esmolol, a short-acting beta-blocking agent, in children.

Authors:  B F Cuneo; V R Zales; P C Blahunka; D W Benson
Journal:  Pediatr Cardiol       Date:  1994 Nov-Dec       Impact factor: 1.655

Review 7.  Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.

Authors:  K Miller
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

Review 8.  Treatment Strategies for Paradoxical Hypertension Following Surgical Correction of Coarctation of the Aorta in Children.

Authors:  Peter P Roeleveld; Eline G Zwijsen
Journal:  World J Pediatr Congenit Heart Surg       Date:  2017-05

9.  Epidurals for Coarctation Repair in Children Are Associated with Decreased Postoperative Anti-Hypertensive Infusion Requirement as Measured by a Novel Parameter, the Anti-Hypertensive Dosing Index (ADI).

Authors:  J Matthew Kynes; Matthew S Shotwell; Camila B Walters; David P Bichell; Jason T Christensen; Stephen R Hays
Journal:  Children (Basel)       Date:  2019-10-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.